6S2I
Anti-tumor antibody 14F7-derived scFv in complex with NeuGc Gm3
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE MASSIF-3 |
Synchrotron site | ESRF |
Beamline | MASSIF-3 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-05-15 |
Detector | DECTRIS EIGER X 4M |
Wavelength(s) | 0.9677 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 62.880, 113.690, 66.950 |
Unit cell angles | 90.00, 91.24, 90.00 |
Refinement procedure
Resolution | 62.865 - 2.285 |
R-factor | 0.2237 |
Rwork | 0.222 |
R-free | 0.25460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6ffj |
RMSD bond length | 0.002 |
RMSD bond angle | 0.542 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX ((1.13_2998: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 62.900 | 2.325 |
High resolution limit [Å] | 2.285 | 2.285 |
Rmerge | 0.097 | 0.697 |
Rmeas | 0.111 | 0.795 |
Rpim | 0.053 | 0.379 |
Number of reflections | 42116 | 2141 |
<I/σ(I)> | 9.03 | 2.1 |
Completeness [%] | 98.8 | 99.1 |
Redundancy | 4.2 | 4.4 |
CC(1/2) | 0.980 | 0.813 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 298 | 12.5 % w/v PEG 1000, 12.5 % w/v PEG 3350, 12.5 % v/v MPD, 0.02 M 1,6-hexandiol, 0.02 M 1-butanol, 0.02 M (RS)-1,2-propanediol, 0.02 M 2-propanol, 0.02 M 1,4-butanediol, 0.02 M 1,3-propanediol, 0.1 M bicine/tris base pH 8.5 |